35507-35-8Relevant articles and documents
Synthesis and X-ray structural characterization of Di-p-aminobenzenediselenide [p-H2NC6H4Se]2 and its mercury(II) derivatives
Bublitz, Fabrcio,De Azevedo Mello, Melina,Durigon, Daniele Cocco,Tirloni, Brbara,Lang, Ernesto Schulz
, p. 2571 - 2576 (2014)
A synthetic route to obtain [p-H2NC6H4Se]2 (1) in good yield was developed, and the crystal structure of the product was characterized for the first time. The synthesis and structure of the mercury(II) derivativ
Enhancing the chemosensitivity of HepG2 cells towards cisplatin by organoselenium pseudopeptides
Shaaban, Saad,Shabana, Sameh M.,Al-Faiyz, Yasair S.,Manolikakes, Georg,El-Senduny, Fardous F.
, (2021/02/26)
Despite all recent advances in the treatment of hepatocellular carcinoma (HCC), chemotherapy resistance still represents a major challenge in its successful clinical management. Chemo-sensitization offers an attractive strategy to counter drug resistance. Herein we report the identification of novel organoselenium-based pseudopeptides as promising highly effective chemo-sensitizers in treating HCC with cisplatin. A series of functionalized pseudopeptide- (5–9 and 17–19), peptidomimetic- (10–12 and 20–23), and tetrazole-based (13–16 and 24–27) organoselenium compounds were synthesized via isonitrile-based multicomponent reactions from two novel selenium-containing isocyanides. All compounds were evaluated for their cytotoxicity against HepG2 and the non-cytotoxic doses were used to restor the sensitivity of the cells to cisplatin. New organoselenium compounds (7, 9, 15, or 23) led to an effective chemo-sensitization of HepG2 cells towards cisplatin (up-to 27-fold). Cell cycle studies indicate that the most potent peptidomimetic diselenide 23 arrested cells at the S phase and induced apoptosis via ROS modulation.
Synthesis and leishmanicidal activity of novel urea, thiourea, and selenourea derivatives of diselenides
Díaz, Marta,de Lucio, Héctor,Moreno, Esther,Espuelas, Socorro,Aydillo, Carlos,Jiménez-Ruiz, Antonio,Toro, Miguel ángel,Gutiérrez, Killian Jesús,Martínez-Merino, Victor,Cornejo, Alfonso,Palop, Juan Antonio,Sanmartín, Carmen,Planoa, Daniel
, (2019/05/21)
A novel series of thirty-one N-substituted urea, thiourea, and selenourea derivatives containing diphenyldiselenide entities were synthesized, fully characterized by spectroscopic and analytical methods, and screened for their in vitro leishmanicidal activities. The cytotoxic activity of these derivatives was tested against Leishmania infantum axenic amastigotes, and selectivity was assessed in human THP-1 cells. Thirteen of the synthesized compounds showed a significant antileishmanial activity, with 50% effective concentration (EC50) values lower than that for the reference drug miltefosine (EC50, 2.84 M). In addition, the derivatives 9, 11, 42, and 47, with EC50 between 1.1 and 1.95 M, also displayed excellent selectivity (selectivity index ranged from 12.4 to 22.7) and were tested against infected macrophages. Compound 11, a derivative with a cyclohexyl chain, exhibited the highest activity against intracellular amastigotes, with EC50 values similar to those observed for the standard drug edelfosine. Structure-activity relationship analyses revealed that N-aliphatic substitution in urea and selenourea is recommended for the leishmanicidal activity of these analogs. Preliminary studies of the mechanism of action for the hit compounds was carried out by measuring their ability to inhibit trypanothione reductase. Even though the obtained results suggest that this enzyme is not the target for most of these derivatives, their activity comparable to that of the standards and lack of toxicity in THP-1 cells highlight the potential of these compounds to be optimized for leishmaniasis treatment.
